The podcast looks at the transformation of clinical trials through technology, with insights from Michael Young of Lindus Health. Lindus Health is the anti-CRO running radically faster, more reliable clinical trials. Michael is a former special advisor to the UK Prime Minister. 

The focus of this episode is on the shift from paper-based to digital processes, emphasising the critical role of a unified data system in conducting more effective trials. Challenges such as the dependency on pilot projects and the slow adoption by CROs are dissected, offering potential pathways for startups to achieve success. Drawing from a background in consulting and government roles, Michael suggests that addressing inefficiencies in current systems could lead to substantial improvements in both clinical trials and broader healthcare solutions.

Reflecting on his subpar Manchester Marathon performance, Matthew draws lessons for clinical trials and business strategy. He underscores the importance of controlling known factors while preparing for unknown challenges. Key strategies include meticulous planning, setting controllable metrics, and developing mental resilience based on the 'Chimp Paradox' to manage emotional responses. By translating the discipline of marathon training into business processes, individuals can better achieve their goals, even amidst adversity, through the power of communication, standard setting, and adaptability.

In this podcast episode, Dr. Kunjan Bhatt explores his extensive role in cardiology, highlighting both the challenges and rewards of leading research efforts at Austin Heart Hospital. He emphasizes the importance of collaboration and innovation in combating the devastating impacts of heart failure. Dr. Bhatt candidly discusses how he manages his multifaceted responsibilities, stressing the necessity of maintaining a balance between professional demands and personal life. As the field of cardiology advances, he underscores the need for continued passion and engagement, reflecting on how these elements have been central to his personal and professional success.

In this podcast episode, Matthew Mace sits down with Anil Kottam and John Porterfield about their journey as independent researchers, focusing on transitioning from early ideas to commercialisation in the medical device field through their practice at BridgeSource Medical. They discuss the importance of SBIR grants for private companies, the challenges of maintaining indirect funding, and the strategies for selecting and developing research projects with commercial viability. Their company is critical in transforming university-backed research into viable products, emphasising the need for collaboration and the innovative spirit that drives technological progress.

Launch of the Pod: Matthew introduces the podcast explaining its aim to share knowledge and strategies for successful clinical trials. They provided a brief overview of their background in clinical cardiology and experience with clinical trials.

Matthew has a background in clinical cardiology, starting in 2009, specializing in heart failure and devices. They have extensive experience in clinical trials, having worked for Abbott and been involved in the development of CardioMEMS. Most recently he led a 1600 Patient study for Acorai as Co-Founder and Chief Scientific Officer.